Showing results (431-440 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|February 27, 2013
Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicineMaša Umićević Mirkov, Marieke J H Coenen
Pharmacogenomics|December 21, 2012
Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemiaMiao Hu, Valiant Wl Mak, Yajie Xiao, et al.
Pharmacogenomics|December 21, 2012
Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexateCristina Lucía Dávila-Fajardo, Jesse J Swen, José Cabeza Barrera, et al.
Pharmacogenomics|December 11, 2012
Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-AmericansAdam Bress, Shitalben R Patel, Minoli A Perera, et al.
Pharmacogenomics|December 11, 2012
Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicityRafid Salim Jabir, Rakesh Naidu, Muhammad Azrif Bin Ahmad Annuar, et al.
Pharmacogenomics|May 19, 2012
A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 alleleMarine L Andersson, Erik Eliasson, Jonatan D Lindh
Pharmacogenomics|May 19, 2012
Pharmacogenomics of osteoporosis: a pathway approachJosé A Riancho, José L Hernández
Pharmacogenomics|October 11, 2014
From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activityNataša Karas-Kuželički, Alenka Šmid, Riin Tamm, et al.
Pharmacogenomics|October 11, 2014
HLA-B*13:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han populationFanping Yang, Bo Gu, Lirong Zhang, et al.
Pharmacogenomics|October 11, 2014
Pharmacogenetic insights into migraine treatment in childrenGiovanna Gentile, Lorenza Chiossi, Luana Lionetto, et al.
Pageof 274